Facilitated By

San Antonio Medical Foundation

News

  • Novavax, Merck rise; Regeneron, Anaplan fall

    The biotechnology company started an early study for a potential coronavirus vaccine. AutoZone Inc., up 26 cents to $1,123.20. The auto parts retailer ...

  • What you need to know today about the virus outbreak

    A U.S. biotechnology company began injecting a coronavirus vaccine candidate into people in Australia with hopes of releasing a proven vaccine this ...

  • Sanofi adds firepower in exiting $13 billion Regeneron stake

    ... fast-growing areas, is sparking speculation he'll hunt for more targets following a deal in December to buy biotech company Synthorx for $2.5 billion.

  • Why COVID-19 immunity passports may violate US law

    As a law professor who has written about legal issues raised by new biotechnologies, I'm concerned about the potential legal and ethical ramifications ...

  • Risks complicate reopenings as WHO warns 1st wave not over

    Tests by a U.S. biotechnology company, Novavax, have begun in Australia with hopes of releasing a proven vaccine this year. A Novavax executive ...